US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.4887 -0.0543 (-10.00%)
Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
From HeartBeam, Inc.
Via Business Wire
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised in the Future of Cardiac Care with Breakthrough Technology
Via Investor Brand Network
Topics Intellectual Property
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Reports Third Quarter 2025 Results
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Advances Remote Cardiac Diagnostics with HeartNexus Partnership
Via Investor Brand Network
Topics Artificial Intelligence Death
HeartBeam Inc. (NASDAQ: BEAT) Recognized as a Top Global Innovator in Portable ECG Technology
Via Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Advances Toward Commercialization of Groundbreaking ECG System
Via Investor Brand Network
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Initiated With Buy Rating and $4 Price Target by Roth Capital
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Third Quarter 2025 Conference Call for Nov. 13
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Partners with HeartNexus to Deliver 24/7 Remote Cardiology Services and Real-Time ECG Interpretation
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere
From HeartBeam, Inc.
Via Business Wire
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Combining Portability and Precision to Redefine Future of Cardiac Care
Via Investor Brand Network
Topics Intellectual Property
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) on the Beat of Cardiac Innovation
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Validates ECG Technology with Strong Results in Pivotal Study
Via Investor Brand Network
Topics Artificial Intelligence
NetworkNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) ECG System Offers Real-Time Cardiac Insights
Via Investor Brand Network
Topics Credit Cards Intellectual Property
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) First-of-Its-Kind Cable-Free ECG Offers Multi-Angle Signal Capture
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Prepares Innovative ECG Technology for Commercial Launch
Via Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Advances Power of ECG with High-Fidelity At-Home Heart-Monitoring System
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG in Detecting Arrhythmias
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam’s Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Profiled on Credit-Card-Sized Device That Synthesizes 12-Lead ECG
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at Three September Investor Conferences
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Advances Patient Convenience with At-Home ECG Technology
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Paves Way to Redefine Cardiac Care
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology
Via Investor Brand Network
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >